Progyny, Inc. to Present at the Jefferies 2022 Healthcare Conference
Progyny, a leader in fertility and family building benefits, will have its CEO Pete Anevski and CFO Mark Livingston engage in a fireside chat at the Jefferies 2022 Healthcare Conference on June 8, 2022, at 10:30 A.M.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Progyny, a leader in fertility and family building benefits, will have its CEO Pete Anevski and CFO Mark Livingston engage in a fireside chat at the Jefferies 2022 Healthcare Conference on June 8, 2022, at 10:30 A.M. Eastern Time. This event will be accessible via a live audiocast on Progyny’s website. The company’s innovative solutions are designed to empower patients and reduce healthcare costs for employers while achieving optimal clinical outcomes. Progyny is headquartered in New York City and has received numerous recognitions for its growth and leadership in the healthcare sector.
Details
News Market Reaction – PGNY
The recorded move for PGNY in the trading session of this news was -6.45%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, June 01, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial Officer, will participate in a fireside chat at the Jefferies 2022 Healthcare Conference on Wednesday, June 8, 2022 at 10:30 A.M. Eastern Time.
A live audiocast and replay will be available from the Events and Presentations section of Progyny’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company in the US. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive fertility solution can simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.
Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Selena Yang
media@progyny.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.